Search by Drug Name or NDC
NDC 24979-0041-13 Megestrol Acetate 125 mg/mL Details
Megestrol Acetate 125 mg/mL
Megestrol Acetate is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TWi Pharmaceuticals, Inc.. The primary component is MEGESTROL ACETATE.
MedlinePlus Drug Summary
Megestrol tablets are used to relieve the symptoms and reduce the suffering caused by advanced breast cancer and advanced endometrial cancer (cancer that begins in the lining of the uterus). Megestrol suspension is used to treat loss of appetite, malnutrition, and severe weight loss in patients with acquired immunodeficiency syndrome (AIDS). Megestrol should not be used to prevent loss of appetite and severe weight loss in patients who have not yet developed this condition. Megestrol is a man-made version of the human hormone progesterone. It treats breast cancer and endometrial cancer by affecting female hormones involved in cancer growth. It increases weight gain by increasing appetite.
Related Packages: 24979-0041-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Megestrol
Product Information
| NDC | 24979-0041 |
|---|---|
| Product ID | 24979-041_94c36a8c-a73f-42af-96d4-09a477627f84 |
| Associated GPIs | 26000023201840 |
| GCN Sequence Number | 059343 |
| GCN Sequence Number Description | megestrol acetate ORAL SUSP 625MG/5ML ORAL |
| HIC3 | C7F |
| HIC3 Description | APPETITE STIM. FOR ANOREXIA,CACHEXIA,WASTING SYND. |
| GCN | 24948 |
| HICL Sequence Number | 003923 |
| HICL Sequence Number Description | MEGESTROL ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Megestrol Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Megestrol Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/mL |
| Substance Name | MEGESTROL ACETATE |
| Labeler Name | TWi Pharmaceuticals, Inc. |
| Pharmaceutical Class | Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203139 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24979-0041-13 (24979004113)
| NDC Package Code | 24979-041-13 |
|---|---|
| Billing NDC | 24979004113 |
| Package | 150 mL in 1 BOTTLE (24979-041-13) |
| Marketing Start Date | 2015-07-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.27245 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | MEGESTROL 625 MG/5 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |